Q1 Earnings Estimate for TSBX Issued By Leerink Partnrs
Turnstone Biologics Corp. (NASDAQ:TSBX – Free Report) – Investment analysts at Leerink Partnrs issued their Q1 2026 earnings per share (EPS) estimates for shares of Turnstone Biologics in a report issued on Tuesday, April 1st. Leerink Partnrs analyst D. Graybosch expects that the company will earn ($0.13) per share for the quarter. The consensus estimate […]
Turnstone Biologics Corp. (NASDAQ:TSBX – Free Report) – Investment analysts at Leerink Partnrs issued their Q1 2026 earnings per share (EPS) estimates for shares of Turnstone Biologics in a report issued on Tuesday, April 1st. Leerink Partnrs analyst D. Graybosch expects that the company will earn ($0.13) per share for the quarter. The consensus estimate […]
